MedTrace Logo

Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer

NCT02577263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2017-03-07

No results posted yet for this study

Summary

The primary objective of this trial is to determine the impact of the FOLFOX regimen on quality of life and the incidence of chemotherapy induced neurotoxicity.

Conditions

  • Stomach Neoplasms

Interventions

OTHER

Quality of life assessment

Quality of life and chemotherapy induced neurotoxicity evaluation

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Chile

    lead OTHER

Principal Investigators

  • Sebastián Mondaca, MD · Pontificia Universidad Catolica de Chile

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-01-31
Completion
2018-06-30

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02577263 on ClinicalTrials.gov